))
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
…
continue reading
An exploration of the digital trends and technology driving change in the biopharmaceutical industry. In-depth conversations with industry leaders at the forefront of transformation.
…
continue reading
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Eva ...
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
…
continue reading
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
…
continue reading
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
…
continue reading
Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a vid ...
…
continue reading
Your trusted partner in pharmaceutical manufacturing. We specialize in high-quality, innovative pharmaceutical products, ensuring healthcare solutions that meet global standards.
…
continue reading
BioPharma EH&S Podcast. The latest discussion on potent compound safety, occupational toxicology, industrial hygiene, and compliance management software. To submit questions or comments to the podcast email affygility@gmail.com or call our listener voicemail line at 206-984-3214.
…
continue reading
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stak ...
…
continue reading
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.
…
continue reading
One-on-one with medical innovators Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collec ...
…
continue reading
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, ...
…
continue reading
Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years. DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go. In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informa ...
…
continue reading
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
…
continue reading
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
…
continue reading
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
1
Rare Insights: Uncovering The Future Of Rare Disease Treatments
Know Rare (Taren Grom, Liz Kay, Kaitlyn Taylor, Nina Wachsman, and DNA Today’s Kira Dineen)
On “Rare Insights” we bridge the gap between those living with rare diseases and the biopharmaceutical industry. Know Rare amplifies the voices of individuals with rare conditions, providing invaluable perspectives to accelerate therapeutic solutions. Join us as we dive deep into the complexities of rare diseases, exploring real-world insights from passionate industry leaders. Together, we navigate the unknowns and unlock the potential for groundbreaking treatments. Because in this journey, ...
…
continue reading
In conversation with APAC's nutrition research pioneers. A podcast brought to you by the team behind NutraIngredients-Asia.com.
…
continue reading
The lastest news in AI and Life Sciences
…
continue reading
TechNation Radio hosted by Dr Moira Gunn
…
continue reading
Kurt Wehrle is a Chicago-based enterprising worldwide business pioneer with 20+ long periods of assorted and progressive P&L management in top-notch Biopharma, Medical Device, and Diagnostic organizations. Kurt Wehrle has a demonstrated history of creating multi-layered worldwide systems, building frameworks, changing business, extending topographies, and creating on the web capacities to essentially expand income and EBITDA.
…
continue reading
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
…
continue reading
Your Brain On... is a podcast by Learning and Development professionals for Learning and Development professionals. Every day, Salience Learning combines the science of learning with expertise in the business of science to help solve the biopharma industry's most complex business challenges. Listen as hosts Karen Foster and Krista Gerhard discuss the latest in cognitive science and learning strategies as they relate to the ever-evolving healthcare industry. In other words: Your Brain On... g ...
…
continue reading
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team an ...
…
continue reading
The AI in Action series of The Alldus Podcast breaks down the hype and explores the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, the premium AI Workforce Solutions, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI across the world.
…
continue reading
Join us as we tackle the essential factors that drive successful commercial products. Our team interviews industry thought leaders to explore regulatory compliance, market trends, and innovation. Stay ahead in this dynamic industry.
…
continue reading
HedgeD, with a capital “D” for emphasis, brings listeners topical content from both sides of the ledger – the long side and the short side. In each episode, co-hosts Mark Yusko, Cory Lester and Andrew Schmeelk take a deep dive into an investment theme or concept, typically with the help of an expert guest from Morgan Creek’s expansive global network.
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on how to use 3D technologies, like 3D printing and bioprinting, AR/VR, and In silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, past Instagram Live interviews, pre ...
…
continue reading
Every medicine in your pharmacy has a human story behind it. Real people doing real work and living real lives. We all have romantic ideas about scientists working late into the evening or doctors dropping everything to answer a phone call about a patient. You can almost envision the moment when one of those researchers finally solves an intellectual puzzle and leaps into action. Their eyes go from an empty stare to an alert laser-like focus. They sit a bit taller and start to read frantical ...
…
continue reading
Explore groundbreaking insights and executive thought leadership in the cannabis industry with our exclusive podcast series. Stay informed, inspired, and ahead of the curve with CannaBiz Conversations - the first podcast for executive thought leadership in the cannabiz.
…
continue reading
The TechCrunch Live Podcast helps founders build better venture backed businesses. Each week, we chat with experienced entrepreneurs and investors on their past wins and losses — particularly the pitches that helped build the business at an early stage.
…
continue reading
Weekly podcast exploring China's business and financial sectors from a legal perspective, brought to you by China Law & Practice. Hosted by Vincent Chow.
…
continue reading
Join us as we swap ideas with thinkers, innovators and doers from around the world and around L.E.K. Presented by consulting powerhouse L.E.K. Consulting (www.lek.com), Insight Exchange™ is a new forum dedicated to the free and open exchange of the most interesting, important, and urgent ideas in the world of business. From the farthest-reaching environmental issues to innovations in retail, industrials, and healthcare, every installment of Insight Exchange™ invites luminaries to tell us wha ...
…
continue reading
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
…
continue reading
At Fierce Biotech, we love a big M&A deal, but valuation does not always equal the most exciting. In this week's episode of "The Top Line," Fierce Biotech’s Annalee Armstrong and James Waldron discuss what they think are the best and smartest acquisitions in recent years. From obesity to radiopharmaceuticals, they give you the Fierce Biotech team’s…
…
continue reading
1
FDA Approval! A New Model for BioPharma... Dr. Sam Blackman, Founder & Head of Research and Development, One Day Biopharmaceuticals
31:10
31:10
Play later
Play later
Lists
Like
Liked
31:10
This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. He talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved dru…
…
continue reading
1
Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24
43:40
43:40
Play later
Play later
Lists
Like
Liked
43:40
Nvidia notching another day of losses, but the broader markets aren’t taking it too hard. How investors are handling the semi slide. Plus A big jump for one biopharma stock as Alnylam delivers promising new heart drug results. What the CEO had to say about the data, and the impact it could have on the space. Fast Money Disclaimer…
…
continue reading
1
E518 Drew Linsley, Co-Founder and CEO at Operant Biopharma
24:52
24:52
Play later
Play later
Lists
Like
Liked
24:52
Today's guest is Drew Linsley, Co-Founder and CEO at Operant Biopharma. Operant Biopharma's AI-powered robotic microscope learns to design drugs by watching and controlling diseases over time. Their platform autonomously designs biological experiments, discovering and optimizing disease treatments. The company focuses on high-need areas like neurod…
…
continue reading
1
Pharma Understands Phase One Data – But Does the Market?
25:30
25:30
Play later
Play later
Lists
Like
Liked
25:30
Public biotech Pyxis Oncology is taking forward its innovative work on ADCs. President and CEO, Lara Sullivan, explains the company’s journey to find the right investors, and why she believes the markets still have some learning to do when analyzing data from early-stage studies.By RBC Capital Markets
…
continue reading
1
True DEI Value in Biopharma with Arcellx's Rami Elghandour
1:04:08
1:04:08
Play later
Play later
Lists
Like
Liked
1:04:08
We love to hear from our listeners. Send us a message. The cell therapy company Arcellx has, by any and every measure, been outperforming its peers. Its stock has rallied on the back of the strong performance of its multiple myeloma candidate, and the promise of its AML, MDS, and solid tumor pipelines is attracting the kind of interest it takes to …
…
continue reading
1
Secrets of Biopharma Tech Transfers: Lessons Learned and Best Practices
24:05
24:05
Play later
Play later
Lists
Like
Liked
24:05
Biologic drug developers face a persistent challenge - executing successful tech transfers of their processes between sites and scales. These transfers are pivotal but extremely complex, prone to issues from changes in facilities, equipment, materials, and process nuances. Failed or delayed tech transfers can derail entire programs, costing compani…
…
continue reading
1
Unlocking Growth: How Digital Innovation is Transforming Commercial Manufacturing
33:42
33:42
Play later
Play later
Lists
Like
Liked
33:42
In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares his insights on Vertex's strategic evolution and its commitment to seri…
…
continue reading
1
Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies
17:20
17:20
Play later
Play later
Lists
Like
Liked
17:20
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Joaquim Vives, head of production of advanced therapies at Banc de Sang i Teixits, discuss cell and gene therapies and what sets them apart from other therapeutics in terms of their processes. Vives also talks about the top characteristics of good starting materials and particular…
…
continue reading
1
Niklas Blomberg, Executive Director, EU Innovative Health Initiative
19:58
19:58
Play later
Play later
Lists
Like
Liked
19:58
In this Vital Health Podcast, recorded live at the 2024 Bio International Conference, host Duane Schulthess sits down with Niklas Blomberg, the Executive Director of the EU Innovative Health Initiative (IHI). Together, they delve into the transformative journey from the Innovative Medicines Initiative to the broader, more inclusive Innovative Healt…
…
continue reading
1
Solving Genetic Diseases??? Dr. Neil Kumar, Founder & CEO, BridgeBio Pharma
23:18
23:18
Play later
Play later
Lists
Like
Liked
23:18
This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of mu…
…
continue reading
1
ServiceNow Series E166: Holger Brink, Technical Director & Chief ServiceNow Architect at NetImpact Strategies
23:46
23:46
Play later
Play later
Lists
Like
Liked
23:46
Today's guest is Holger Brink, Technical Director and Chief ServiceNow Architect at NetImpact Strategies. Founded in 2009, NetImpact is a leading provider of digital transformation support to the US federal government, renowned for its innovative solutions and comprehensive expertise. With a proven track record of driving technological advancements…
…
continue reading
1
E120 | Can Healthcare Be Made More Accessible and Affordable Through Innovation & Disruptive Thinking?
34:57
34:57
Play later
Play later
Lists
Like
Liked
34:57
In this episode, Dr. Andree Bates speaks with Professor Shafi Ahmed and discusses how innovation and disruptive thinking can transform healthcare, making it more accessible and affordable for everyone. Professor Shafi Ahmed is a renowned surgeon and co-founder of Medical Realities, a company pioneering the use of virtual and augmented reality in me…
…
continue reading
1
Pharma Stocks Get Hit As Biden Weighs In… Plus Tesla’s Delivery Beat 7/2/24
43:40
43:40
Play later
Play later
Lists
Like
Liked
43:40
Eli Lilly and Novo Nordisk getting hit as President Biden says they’re “ripping off Americans”. The rising costs of weight loss drugs, and the political impact on the pharma space. Plus Tesla charges higher. The EV maker reporting strong delivery numbers, extending the stock’s recent win streak. But could shares be nearing a key resistance level? H…
…
continue reading
1
Rohit Sood - Digital Transformation & AI's Role in Life Sciences
44:54
44:54
Play later
Play later
Lists
Like
Liked
44:54
We welcome Rohit Sood to AI Uncovered. Rohit is a seasoned executive with a strong background in commercialization and technology use in life sciences. He currently advises a variety of life science services and Private Equity firms on operations, growth and digital transformation. With over 25 years of experience in the life sciences and technolog…
…
continue reading
1
In Vivo Podcast Episode with Stefan Woxström
27:02
27:02
Play later
Play later
Lists
Like
Liked
27:02
In Vivo Podcast Episode with Stefan Woxström by CitelineBy Citeline
…
continue reading
1
Apple Nears New Highs… And The Second Half Playbook 7/1/24
43:30
43:30
Play later
Play later
Lists
Like
Liked
43:30
Shares of Apple nearing record highs as reports of a China iPhone rebound helps fuel investor optimism. But not everyone’s believing the reversal. What analysts are saying about the recovery in the mainland. Plus Hedging into the second half. After a strong first half, here’s how you should position for the rest of the year. Fast Money Disclaimer…
…
continue reading
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week has seen some exciting advances in neuroscience drug discovery, including Phase II clinical trials for two potentially game-changi…
…
continue reading
1
From Biotech Breakthroughs to Food Tech Revolution: Dr. Ron Shigeta's Journey
1:00:16
1:00:16
Play later
Play later
Lists
Like
Liked
1:00:16
Summary Dr. Ron Shigeta, a pioneer in the biotech startup ecosystem, shares his insights and experiences in this episode. He discusses the success of IndieBio, a biotech accelerator that demonstrated the potential of modest investments in fueling biotech innovations. Dr. Shigeta also highlights the importance of timing, luck, and having a clear vis…
…
continue reading
1
E519 Christian Ferreira, Founder and CEO at PSci.AI
17:12
17:12
Play later
Play later
Lists
Like
Liked
17:12
Today's guest is Christian Ferreira, Founder and CEO at PSci.AI. Founded in 2022, Procurement Sciences AI (PSci.AI) is a trusted partner for GovCon, aerospace, defense, education and other government-oriented businesses, offering a transformative platform powered by breakthrough advancements in Generative AI. Their platform and tools provide invalu…
…
continue reading
1
Topical Ocular Biologics with Claris Bio's Clarke Atwell
58:06
58:06
Play later
Play later
Lists
Like
Liked
58:06
We love to hear from our listeners. Send us a message. Built on the back of hepatocyte growth factor discoveries by Harvard Drs. Reza Dana and Sunil Chauhan, ClarisBio is rewriting the ophthalmology rulebook. CEO Clark Atwell acknowledges that it's not the first to bring topically-administered biologic therapies to the front of the eye, but if succ…
…
continue reading
1
How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
47:55
47:55
Play later
Play later
Lists
Like
Liked
47:55
Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and hea…
…
continue reading
1
Scrip's Five Must-Know Things - 1 July 2024
16:53
16:53
Play later
Play later
Lists
Like
Liked
16:53
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; another late-stage loss for Merck KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models.https://scrip.citeline.com/SC150517/Quick-L…
…
continue reading
1
Virtual Event Recording: 3D Bioprinting Biofabrication for Musculoskeletal Tissues
1:57:51
1:57:51
Play later
Play later
Lists
Like
Liked
1:57:51
This virtual event centered on biofabrication and bioprinting of musculoskeletal tissue. As the demand for effective treatments for bone and cartilage defects continues to rise with an aging population, this event is a vital platform for deep conversations about the challenges, progress, and future of tissue engineering for regenerative purposes in…
…
continue reading
1
Over the Counter: EPR Consultant Urges Producers To Start Collecting Packaging Data
16:55
16:55
Play later
Play later
Lists
Like
Liked
16:55
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.…
…
continue reading
1
Nike’s Historic Drop… And Payment Stocks Getting Burned 6/28/24
43:51
43:51
Play later
Play later
Lists
Like
Liked
43:51
Shares of Nike plummeting after reporting results, as the sneaker giant warns of a major sales slowdown. But one of our traders is using the plunge as an opportunity. Plus the fast food price wars are heating up, but could the payment stocks be getting burned in the process. How that space is being impacted. Fast Money Disclaimer…
…
continue reading
1
Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming
35:29
35:29
Play later
Play later
Lists
Like
Liked
35:29
Pink Sheet reporter and editors discuss what the FDA included in its long-awaited guidance on clinical trial diversity action plans, along with what was left out (:35), as well as an upcoming guidance on the use of artificial intelligence in regulatory decision-making (27:30).More On These Topics From The Pink SheetDiversity Action Plans Should Be …
…
continue reading
1
Pharma Matters Podcast: Contract Pharma Talks with Tom Wilson of Pfizer CentreOne
29:59
29:59
Play later
Play later
Lists
Like
Liked
29:59
Vice President and Global Contract Manufacturing Leader for Pfizer CentreOne talks about supply chain reliability trends.By Tom
…
continue reading
On this week’s Tech Nation, Moira speaks with Stanford Business School Lecturer, Matt Abrahams, about his book, “THINK FASTER, TALK SMARTER: How To Speak Successfully When You’re Put on the Spot”. Then, Dr. Steffen-Sebastian Bolz from Aphaia Pharma talks about their new drug, currently in phase 3 trial, that may provide the benefits of Ozempic and …
…
continue reading
1
Nike Reports Results… And Economic Track Records Ahead Of Presidential Debate 6/27/24
43:43
43:43
Play later
Play later
Lists
Like
Liked
43:43
Nike swooshing lower after reporting a revenues miss. The details out of the company’s conference call, and how you should play the retailer. Plus Presidential impact. A look at the economic records under President Biden and Former Presiden Trump, as the two go head-to-head in tonight’s presidential debate. Fast Money Disclaimer…
…
continue reading
1
How AI ls Reshaping the Future of Healthcare
1:00:21
1:00:21
Play later
Play later
Lists
Like
Liked
1:00:21
Subodha Kumar, professor of statistics, operations, and data science and the founding director of the Center for Business Analytics and Disruptive Technologies at Temple University’s Fox School of Business, sits down with Amar Drawid to discuss how AI will improve operational efficiency in healthcare, enable mass customization for patients, and fre…
…
continue reading
1
Ep. 63 - Day One's Jeremy Bender: Building Pediatric Oncology from the Ground Up
32:27
32:27
Play later
Play later
Lists
Like
Liked
32:27
Pediatric cancer drug development is difficult: it requires high levels of safety, involves parents as well as the patients, and has small populations that can make it difficult to achieve the revenues that reward the investment. Squaring that circle, according to Day One Biopharmaceuticals CEO Jeremy Bender, is not impossible, but takes a dedicate…
…
continue reading
1
Nvidia’s Shareholder Meeting…. And Bank Stress Test Results 6/26/24
43:37
43:37
Play later
Play later
Lists
Like
Liked
43:37
Nvidia leading a semi selloff, as the company’s shareholder meeting sheds light on growing competition. What the moves mean for the chip trade. Plus Bank stocks in focus after the Fed’s stress test results. Why one investment firm’s CEO says the group is in great shape. Fast Money DisclaimerBy CNBC
…
continue reading
1
The Next Ozempic or Wegovy... But Without the Injection??? Dr. Steffen-Sebastian Bolz, CSO, Aphaia Pharma
25:16
25:16
Play later
Play later
Lists
Like
Liked
25:16
What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 2.By Moira Gunn
…
continue reading
